The top 20 Health Executive stories for February 2022

Dave Fornell | | Health Exec | Economics
Two of the top stories this month was Forbes' list of leading U.S. hospitals, and the release of the 2022 Best in KLAS vendors health IT vendors to work with.
Two of the top stories this month was Forbes' list of leading U.S. hospitals, and the release of the 2022 Best in KLAS vendors health IT vendors to work with.

These were the most popular stories on Health Exec in February 2022:

1. Most physicians still paid based on volume, despite efforts to incentivize value-driven care

2. Time to rethink how we compensate nonprofit hospital CEOs, think tank says

3. ‘Cause for concern’: Physicians in the same health system make vastly different choices for identical patients

4. Prior authorization adversely impacts patient care, workforce productivity

5. 48 hospitals make Forbes’ list of best employers

6. CVS seeks to relieve overworked pharmacists with new policy

7. Mayo Clinic’s hybrid Care Hotel earns good grades from patients

8. Kaiser Permanente's 'secret' Medicaid deal with California raises eyebrows

9. Hospital CEOs say workforce shortages were more challenging than financials in 2021

10. Hospitals share top health IT vendors to work with in the Best in KLAS 2022 list
 

11. Amazon Care announces plans to expand in-person services nationwide

12. Specialty pharmacies offer more affordable drug prices than hospitals

13. Health-tech companies back new legislation introduced to modernize ‘outdated’ health privacy laws

14. AI-based system affords physicians more flexible schedules, minimizes burnout triggers

15. American Hospital Association responds to changing healthcare landscape with new strategic plan

16. Consumers struggle to understand quarantine guidance following at-home COVID test results

17. Small, rural hospitals struggle to retain staff lured away by big paydays

18. Cardinal Health will pay $13M to settle kickback allegations

19. Oracle’s $28.3B deal to buy Cerner facing antitrust scrutiny, additional lawsuits

 

Related top news stories content:

Most popular stories in Radiology Business from February 2022

The top 20 Cardiology Business stories for February 2022

Top Health Imaging stories in February 2022

Dave Fornell is a digital editor with Cardiovascular Business and Radiology Business magazines. He has been covering healthcare for more than 16 years.
Dave Fornell

Dave Fornell has covered healthcare for more than 17 years, with a focus in cardiology and radiology. Fornell is a 5-time winner of a Jesse H. Neal Award, the most prestigious editorial honors in the field of specialized journalism. The wins included best technical content, best use of social media and best COVID-19 coverage. Fornell was also a three-time Neal finalist for best range of work by a single author. He produces more than 100 editorial videos each year, most of them interviews with key opinion leaders in medicine. He also writes technical articles, covers key trends, conducts video hospital site visits, and is very involved with social media. E-mail: [email protected]

Related Content

Eli Lilly to acquire gene-editing specialists focused on CVD for up to $1.3B
Why more doctors should pursue business and leadership training
Q&A: The role of employers in achieving healthcare price transparency
Medtronic’s diabetes spin-off gets a name, kicking off ‘new and exciting chapter’
Smaller revenues, less growth: In US, tariffs may create headaches for $34.5B cardiovascular device market
How private equity influences care for heart failure patients

Around the web

Cardiovascular Business
Eli Lilly to acquire gene-editing specialists focused on CVD for up to $1.3B

The company has agreed to acquire Verve Therapeutics for an upfront payment of approximately $1 billion. The total could increase significantly, however, if certain milestones are met. One of Verve's biggest gene therapies has already received the FDA's fast track designation.

Cardiovascular Business
AMA House of Delegates helps cardiology groups influence healthcare policies

American College of Cardiology Board of Governors Chair David E. Winchester, MD, MS, examines the many benefits of working with the American Medical Association House of Delegates to bring about significant change.

Cardiovascular Business
Smaller revenues, less growth: In US, tariffs may create headaches for $34.5B cardiovascular device market

“Without a more concrete and stable policy on these tariffs from the current American administration, it is likely that most manufacturers will be forced to continuously change their internal forecasts and production plans," one analyst said.